Table 3.
Percentage (%) | Swim speed (cm/s) | |
---|---|---|
Control | 40.6 ±5.1 | 28.3 ±2.2 |
Sham | 43.9 ±4.0 | 27.6 ±2.0 |
TBI | 23.2 ±3.0a,b | 27.3 ±2.5 |
TBI + L | 26.0 ±2.3a,b | 27.6 ±2.1 |
TBI + M | 31.5 ±2.8a,b,c | 28.1 ±3.0 |
TBI + H | 35.6 ±4.1a,b,c | 28.0 ±3.2 |
Control – control group; Sham – sham group; TBI – TBI group; TBI + L – rhamnetin low-dose group; TBI + M – rhamnetin middle-dose group; TBI + H – rhamnetin high-dose group. The probe trial consisted of a single 30-second trial. Data were expressed as mean ± SD (N = 10 per group) and were analysed using one-way ANOVA with subsequent SNK test.
p < 0.05, vs. the control group
p < 0.05, vs. the sham group
p < 0.05, vs. the TBI group